Lioresal Intrathecal

Baclofen, the active ingredient in Lioresal Intrathecal, is a GABA_B receptor agonist presented as an intrathecal solution for intrathecal use. It is employed to treat spasticity associated with multiple sclerosis, spinal cord injury, and cerebral palsy. GNH USA supplies Lioresal Intrathecal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Lioresal Intrathecal acts on the central nervous system to reduce abnormal muscle tone in various neurological conditions.

Multiple sclerosis–related spasticity: reduces muscle tone and improves mobility. Spinal cord injury–associated spasticity: decreases involuntary muscle contractions. Cerebral palsy spasticity: alleviates stiffness and facilitates functional movement.

Adverse reactions may occur with intrathecal baclofen therapy.

Common Side Effects: - Dizziness - Fatigue - Headache - Nausea - Constipation - Injection‑site irritation

Serious or Rare Side Effects: - Hypotension - Respiratory depression - Seizures - Severe allergic reactions (anaphylaxis) - Urinary retention - Hallucinations or psychosis

When using Lioresal Intrathecal, consider the following safety measures.

Renal impairment: monitor renal function and adjust therapy as needed. Hepatic impairment: use with caution and observe liver parameters. Concomitant CNS depressants: increased risk of sedation and respiratory depression. Pregnancy: safety not established; avoid unless benefits outweigh risks. Abrupt discontinuation: may cause severe withdrawal symptoms; taper under medical supervision. Store at ambient temperature: keep in original container, protect from light and moisture.

Baclofen may interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Opioids: additive central nervous system depression. - Benzodiazepines: enhanced sedation and respiratory depression. - Antihypertensives: increased risk of hypotension.

Moderate Interactions (Monitor Closely): - Anticonvulsants: may alter baclofen plasma levels. - Alcohol: potentiates sedative effects. - CYP450 inhibitors: possible increase in baclofen exposure.